These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of 2-hydroxypropyl-beta-cyclodextrin on pharmacokinetics of digoxin in rabbits and humans. He ZG; Li YS; Zhang TH; Tang X; Zhao C; Zhang RH Pharmazie; 2004 Mar; 59(3):200-2. PubMed ID: 15074593 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers. Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292 [TBL] [Abstract][Full Text] [Related]
7. Absorption of digoxin from tablets and capsules in subjects with malabsorption syndromes. Heizer WD; Pittman AW; Hammond JE; Fitch DD; Bustrack JA; Hull JH DICP; 1989 Oct; 23(10):764-9. PubMed ID: 2815851 [TBL] [Abstract][Full Text] [Related]
8. Effects of terbinafine on the pharmacokinetics of digoxin in healthy volunteers. Tarral A; Francheteau P; Guerret M Pharmacotherapy; 1997; 17(4):791-5. PubMed ID: 9250559 [TBL] [Abstract][Full Text] [Related]
9. Comparison of steady-state serum concentrations of digoxin in tablets (Lanoxin) and capsules (Lanoxicaps) in the elderly. Pouwels MJ; Hooymans PM; van der Aa GC; Gribnau FW DICP; 1991 Oct; 25(10):1043-6. PubMed ID: 1803786 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations. Wagner JG; Stoll RG; Weidler DJ; Ayres JW; Hallmark MR; Sakmar E; Yacobi A J Pharmacokinet Biopharm; 1979 Apr; 7(2):147-58. PubMed ID: 20218011 [TBL] [Abstract][Full Text] [Related]
11. Bioavailability studies with Digoxin-Sandoz and Lanoxin. Beveridge T; Kalberer F; Nüesch E; Schmidt R Eur J Clin Pharmacol; 1975 Jun; 8(5):371-6. PubMed ID: 1243983 [TBL] [Abstract][Full Text] [Related]
13. Do therapeutic doses of acarbose alter the pharmacokinetics of digoxin? Cohen E; Almog S; Staruvin D; Garty M Isr Med Assoc J; 2002 Oct; 4(10):772-5. PubMed ID: 12389338 [TBL] [Abstract][Full Text] [Related]
14. Single dose bioavailability of two different digoxin tablets. Jonkman JH; Gusdorf CF; van der Boon WJ; Grasmeijer G; Jedema JN Arzneimittelforschung; 1987 Jan; 37(1):62-5. PubMed ID: 3566859 [TBL] [Abstract][Full Text] [Related]
15. Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers. Galán-Herrera JF; Poo JL; Maya-Barrios JA; de Lago A; Oliva I; González-de la Parra M; Jiménez P; López-Bojórquez E; Burke-Fraga V; Namur S Clin Ther; 2008 Sep; 30(9):1667-74. PubMed ID: 18840372 [TBL] [Abstract][Full Text] [Related]
16. Lack of effect of eprosartan on the single dose pharmacokinetics of orally administered digoxin in healthy male volunteers. Martin DE; Tompson D; Boike SC; Tenero D; Ilson B; Citerone D; Jorkasky DK Br J Clin Pharmacol; 1997 Jun; 43(6):661-4. PubMed ID: 9205830 [TBL] [Abstract][Full Text] [Related]
17. The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol. O'Grady J; Johnson BF; Bye C; French J Eur J Clin Pharmacol; 1978 Dec; 14(5):357-60. PubMed ID: 729628 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers. Iqbal M; Khuroo A; Batolar LS; Tandon M; Monif T; Sharma PL Clin Ther; 2010 Mar; 32(3):588-96. PubMed ID: 20399995 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin in healthy volunteers. Harder S; Thürmann PA Br J Clin Pharmacol; 1997 May; 43(5):475-80. PubMed ID: 9159562 [TBL] [Abstract][Full Text] [Related]
20. Single dose bioequivalence study of two brands of olanzapine 10 mg tablets in Iranian healthy volunteers. Zakeri-Milani P; Islambulchilar Z; Ghanbarzadeh S; Valizadeh H Drug Res (Stuttg); 2013 Jul; 63(7):346-50. PubMed ID: 23605469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]